AI is transforming the future of longevity, and the impact on healthcare and insurance is profound.
Our Founding Partner Sam Evans shares his perspective in Insurance CIO Outlook on how advances in artificial intelligence, epigenetics, and next-generation therapeutics are redefining how we detect, manage, and prevent disease.
The shift is radical: from reactive “sick care” systems to proactive prevention and prediction. From AI-powered CCTA scans that predict cardiovascular events based on plaque characteristics, to personalized health plans and cutting-edge therapeutics like stem cell treatments.
As Sam writes:
“There is an opportunity to offer the next generation of wellness-focused insurance products through the integration of longevity to extend healthspans and reduce mortality rates at significantly lower costs.”
The timeline matters: it currently takes 17 years for medical breakthroughs to reach healthcare frontlines. Insurance can accelerate this adoption and democratize access to life-extending technologies.
At Eos Ventures, we invest where AI, technology and healthcare innovation meet the insurance sector, partnering with companies that are building the infrastructure to integrate these breakthroughs into insurance products and accelerate market adoption.
What investment opportunities emerge when insurance shifts from sick care to prevention?
Read More: Insurance CIO Outlook
